Timothy Smith on AI, Data, and Drug Discovery at Takeda

Episode notes

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Timothy Smith, Senior Director of AI Innovation and Head of the Data Sciences Communities at Takeda, to explore how AI is transforming drug discovery and development, why trust and governance are still major hurdles, and why the biggest bottleneck in pharma innovation might not be technology but people. Pharma Sessions provides general insights into the pharmaceutical and life sciences industry through conversations with its guests. The content shared in this podcast is for informational purposes only and should not be considered medical, legal, regulatory, or financial advice. The use of any information discussed in this episode or materials linked from the podcast is at the listener’s own risk. The views and opinions expressed by guests are their own and do not necessarily reflect the views of Jonathan Kaskey, Pharma Sessions, its sponsors, or affiliated organizations. Any reference to specific products, companies, regulatory pathways, or commercial strategies is provided for discussion purposes only and does not constitute endorsement or validation by the podcast, host, or sponsors.

• The Question Behind the Question - Field Training with Jennifer Muszik47 / 100
• Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce46 / 100
• Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury49 / 100
• Lessons on Leading Through Uncertainty in Pharma
• Where AI Delivers Real Value in Pharma Today with Emily Lewis